Stay updated on Safety and Immunogenicity of VLA2001 in Adults Aged ≥56 Years Clinical Trial
Sign up to get notified when there's something new on the Safety and Immunogenicity of VLA2001 in Adults Aged ≥56 Years Clinical Trial page.

Latest updates to the Safety and Immunogenicity of VLA2001 in Adults Aged ≥56 Years Clinical Trial page
- Check6 days agoChange DetectedThe study results view displays a 403 Forbidden error and a Home link instead of study results.SummaryDifference0.5%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe study results page now displays a 403 Forbidden error, replacing the usual study results view with a generic error page. This blocks access to the trial's results and related details.SummaryDifference6%

- Check41 days agoChange DetectedRevision: v3.6.6 is now displayed, replacing Revision: v3.6.5. This indicates a minor site version update to the ClinicalTrials.gov interface.SummaryDifference0.1%

- Check62 days agoChange DetectedFooter now displays Revision: v3.6.5, replacing Revision: v3.6.4, signaling a new site build.SummaryDifference0.1%

- Check76 days agoChange DetectedThe site’s version label updated from v3.6.3 to v3.6.4, indicating a platform update. The change is primarily a backend/version bump and does not alter the visible study details or results page.SummaryDifference0.1%

- Check98 days agoChange DetectedThe footer now shows Revision: v3.6.3, replacing the previous version, indicating a minor site update to the revision history.SummaryDifference0.1%

Stay in the know with updates to Safety and Immunogenicity of VLA2001 in Adults Aged ≥56 Years Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety and Immunogenicity of VLA2001 in Adults Aged ≥56 Years Clinical Trial page.